Keywords: axcan, urso, efficacy, says, firm, pharma, maintains

Axcan's URSO 250 has efficacy, says firm

Article | 12 August 2002

Print This

Axcan Pharma maintains that a Phase II trial of its URSO 250 (ursodiol)has achieved positive results, even though it missed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in